WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Bionyra's $165M launch: A Sanofi alum, I&I candidates from China, one big catch-up

Former Sanofi I&I exec Frédéric Marrache launches Bionyra with $165M to chase TL1A targets in IBD and eczema.

Raccontata dabiopharmadive.comendpoints.news

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
endpoints.newsStai leggendo9 g fa

Bionyra's $165M launch: A Sanofi alum, I&I candidates from China, one big catch-up

Former Sanofi I&I exec Frédéric Marrache launches Bionyra with $165M to chase TL1A targets in IBD and eczema.

originale
biopharmadive.com10 g fa

Bionyra brings in $165M for next-generation immune drugs

The biotech, co-founded by Sofinnova Partners and a former Sanofi immunology R&D head, is testing new biologics against common immune conditions.

Leggi questa versione → originale

Timeline cronologica

  1. lunedì 22 giugno 2026·biopharmadive.com

    Bionyra brings in $165M for next-generation immune drugs

    The biotech, co-founded by Sofinnova Partners and a former Sanofi immunology R&D head, is testing new biologics against common immune conditions.

  2. lunedì 22 giugno 2026·endpoints.news

    Bionyra's $165M launch: A Sanofi alum, I&I candidates from China, one big catch-up

    Former Sanofi I&I exec Frédéric Marrache launches Bionyra with $165M to chase TL1A targets in IBD and eczema.